Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-21

Clinical Trial Update: Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is studying nicotinamide riboside for lowering elevated systolic blood pressure and reducing arterial stiffness in middle-aged and olde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotinamide Riboside (nicotinamide riboside)

Snippet

Sponsor: Douglas Seals | Conditions: Hypertension, Aging | Phase 2 | Status: RECRUITING